Common Approach to Metabolic-Associated Fatty Liver Disease in Patients With Psoriasis: Consensus-Based Recommendations From a Multidisciplinary Group of Experts. / Abordaje común del paciente con psoriasis y riesgo de esteatosis hepática metabólica: recomendaciones de un grupo de expertos multidisciplinar.
Actas Dermosifiliogr
; 114(5): 392-401, 2023 May.
Article
en En, Es
| MEDLINE
| ID: mdl-36720362
ABSTRACT
Recent years have seen concerted efforts to understand the relation between psoriasis and metabolic-associated fatty liver disease (MAFLD). Not only is MALFD diagnosed more often in patients with psoriasis, but its clinical course is also more aggressive. A common approach is therefore needed to enable early detection of liver disease coincident with psoriasis. Especially important is an analysis of risks and benefits of potentially hepatotoxic treatments. This consensus paper presents the recommendations of a group of experts in dermatology and hepatology regarding screening for MALFD as well as criteria for monitoring patients and referring them to hepatologists when liver disease is suspected.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Psoriasis
/
Enfermedad del Hígado Graso no Alcohólico
/
Gastroenterología
Tipo de estudio:
Diagnostic_studies
/
Guideline
/
Risk_factors_studies
/
Screening_studies
Límite:
Humans
Idioma:
En
/
Es
Revista:
Actas Dermosifiliogr
Año:
2023
Tipo del documento:
Article